Charles River Laboratories International (CRL) Return on Equity (2016 - 2025)
Historic Return on Equity for Charles River Laboratories International (CRL) over the last 16 years, with Q3 2025 value amounting to 0.02%.
- Charles River Laboratories International's Return on Equity fell 1400.0% to 0.02% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02%, marking a year-over-year decrease of 1400.0%. This contributed to the annual value of 0.01% for FY2024, which is 1400.0% down from last year.
- According to the latest figures from Q3 2025, Charles River Laboratories International's Return on Equity is 0.02%, which was down 1400.0% from 0.02% recorded in Q2 2025.
- Over the past 5 years, Charles River Laboratories International's Return on Equity peaked at 0.18% during Q2 2021, and registered a low of 0.02% during Q3 2025.
- Over the past 5 years, Charles River Laboratories International's median Return on Equity value was 0.15% (recorded in 2023), while the average stood at 0.12%.
- Per our database at Business Quant, Charles River Laboratories International's Return on Equity surged by 1400bps in 2021 and then tumbled by -1400bps in 2025.
- Quarter analysis of 5 years shows Charles River Laboratories International's Return on Equity stood at 0.16% in 2021, then rose by 9bps to 0.18% in 2022, then dropped by -21bps to 0.14% in 2023, then crashed by -95bps to 0.01% in 2024, then plummeted by -437bps to 0.02% in 2025.
- Its last three reported values are 0.02% in Q3 2025, 0.02% for Q2 2025, and 0.01% during Q1 2025.